| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0362 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567 |
| filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4622b9783daeb856b3597c6925e902a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5748eda68f8eabb142039428d3edd613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b20339b6669d12745bb83ecc11381f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2714790007615645c84d6968ff8f99 |
| publicationDate |
2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7815895-B2 |
| titleOfInvention |
Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith |
| abstract |
A method for activating an efferent sympathetic nerve innervating an adipose tissue and improving obesity-associated symptoms is provided, comprising stimulating an afferent vagal nerve from the liver without directly enhancing peroxisome proliferator-activated receptor (PPAR)-γ2 function in the liver. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006195153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8588930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8352026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8165695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8583256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8751003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7979137-B2 |
| priorityDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |